W. Jin

Low toxicity and high immunogenicity of an inactivated vaccine candidate against COVID-19 in different animal models

L. Fu, Changgui Li, S. Shen, 2020, Emerging microbes & infections.

Biochemical and antigenic characterization of the structural proteins and their post-translational modifications in purified SARS-CoV-2 virions of an inactivated vaccine candidate

D. Liu, S. Shen, Kai Duan, 2020, Emerging microbes & infections.

Pradefovir Treatment in Patients With Chronic Hepatitis B: Week 24 Results From a Multicenter, Double-Blind, Randomized, Noninferiority, Phase 2 Trial

Yan Peng, J. Niu, Liang Chen, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Safety, efficacy, and pharmacokinetics of pradefovir for the treatment of chronic hepatitis B infection.

Xiaojiao Li, Hong Zhang, Yanhua Ding, 2019, Antiviral research.

Emergence of a novel recombinant of CV-A5 in HFMD epidemics in Xiangyang, China

X. Guan, Y. Tong, S. Shen, 2021, BMC medical genomics.

Identification of specific and shared epitopes at the extreme N-terminal VP1 of Coxsackievirus A4, A2 and A5 by monoclonal antibodies

S. Shen, Zejun Wang, Mengli Wang, 2023, Virus research.

Efficacy of Coxsackievirus A5 Vaccine Candidates in an Actively Immunized Mouse Model

S. Shen, Zejun Wang, Jia Lu, 2021, Journal of Virology.

Identification of a Conserved, Linear Epitope on VP3 of Enterovirus A Species Recognized by a Broad-Spectrum Monoclonal Antibody

S. Shen, Zejun Wang, Chen Wang, 2023, Viruses.

Reporter Coxsackievirus A5 Expressing iLOV Fluorescent Protein or Luciferase Used for Rapid Neutralizing Assay in Cells and Living Imaging in Mice

Zejun Wang, Sheng-li Meng, Jing Guo, 2023, Viruses.

Novel coronavirus disease with conjunctivitis and conjunctivitis as first symptom: Two cases report

Yanning Yang, W. Jin, Ming Wang, 2020 .